Ikonisys FY25 net loss widens to EUR 4.2 million; net sales rise 37.3% to EUR 1.39 million

Reuters2026/07/30 19:49

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Ikonisys posted FY 2025 net sales of €1.39 million, up 37.3%.
Net loss widened to €4.2 million; operating loss widened to €3.9 million.
EBITDA loss narrowed to €1.14 million from €1.7 million.
Cash and cash equivalents rose to €1.03 million at year-end.
Update: US patent for ACTA, Urine24 launched in Italy, exclusive Italian distribution deal signed with Menarini Diagnostics.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ikonisys SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260730279932) on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Ikonisys FY25 net loss widens to EUR 4.2 million; net sales rise 37.3% to EUR 1.39 million

You may also like

Crypto prices